{"denoms":[{"counts":[{"groupId":"BG000","value":"79"},{"groupId":"BG001","value":"39"},{"groupId":"BG002","value":"118"}],"units":"Participants"}],"groups":[{"description":"Study drug was given by continuous oral daily dosing of two 5 mg tablets.","id":"BG000","title":"Everolimus"},{"description":"Placebo was given by continuous oral daily dosing of two 5 mg tablets.","id":"BG001","title":"Placebo"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.37","value":"32.5"},{"groupId":"BG001","spread":"9.64","value":"31.0"},{"groupId":"BG002","spread":"10.12","value":"32.0"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"55"}]}],"title":"<30 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"63"}]}],"title":"≥ 30 years"}],"paramType":"NUMBER","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"52"},{"groupId":"BG001","value":"26"},{"groupId":"BG002","value":"78"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"40"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Gender","unitOfMeasure":"Participants"}]}